Tilray | TRLY - 现金及等价物



金融业
股票价格
USD
资产
USD 2.1B
现金及等价物
USD 264.83M
销售成本
USD 164.37M
流动资产
USD 729.32M
流动负债
USD 259.32M
债务
USD 640.95M
EBIT
USD -20.01M
EBITDA
USD 8.37M
员工
USD 2.84K
EPS每股收益
USD -0.41
股本和储备
USD 1.58B
销售毛利
USD 57.47M
债务利息支出
USD 6.7M
利息收入
USD 12.83M
贷款资金
USD 268.59M
市值
USD 4.82B
净收入
USD -44.93M
营业费用
USD 237.52M
营业利润
USD -20.01M
普通股股本
USD 116.52M
PE价格收益
11.57
税前利润
USD -39.96M
销售收入
USD 217.51M
销售和管理费用
USD 24.85M
股票
USD 282.79M
贸易债权人
USD 114.5M
应收帐款人
USD 109.07M


现金及等价物 更改 日
Acasti Pharma USD 18.67M 1.81M 2025-12
Akebia Therapeutics USD 155.55M 7.1M 2026-06
Alaunos Therapeutics USD 354K 1.03M 2026-03
Aurora Cannabis CAD 64.69M 8.33M 2026-03
Avita Medical AUD 10.24M 1.98M 2025-12
Canopy Growth CAD 364.68M 6.64M 2026-03
Cronos Group USD 467.02M 354.84M 2026-06
Dianthus Therapeutics USD 110.55M 517.12M 2026-06
Divis Laboratories Ltd INR 1.28B 2.87B 2026-03
Ionis Pharmaceuticals USD 350.06M 1.57B 2026-06
IQVIA Holdings USD 1.91B 38M 2026-06
Knight Therapeutics CAD 76.45M 5.43M 2025-12
Moderna USD 1.72B 185M 2026-06
Organigram Holdings CAD 4.29M 3.28M 2026-03
Organon & Co USD 1.13B 16M 2026-06
Revvity USD 1.02B 162.62M 2026-06
Tectonic Therapeutic USD 236.89M 16.9M 2026-03
Tilray USD 264.83M 43.16M 2025-06
Viatris USD 886.5M 917.7M 2026-06
Xeris Pharmaceuticals USD 121.75M 10M 2026-06
Zealand Pharma A/S 3.85B 727.54M 2026-03